- Record: found
- Abstract: not found
- Article: not found
A Randomized Trial of Mometasone Furoate 0.1% to Reduce High-Grade Acute Radiation Dermatitis in Breast Cancer Patients Receiving Postmastectomy Radiation
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A 2-arm, double-blinded randomized trial was conducted to evaluate the efficacy of
0.1% mometasone furoate (MF) versus Eucerin Original (E) cream in preventing the development
of moderate to severe acute radiation dermatitis (ARD) in breast cancer patients receiving
postmastectomy radiation (PMRT).